AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1,178 Cr | ₹-990 Cr | ₹-856 Cr | ₹-288 Cr | ₹122 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-1,178 Cr |
| Mar2025 | ₹-990 Cr |
| Mar2024 | ₹-856 Cr |
| Mar2023 | ₹-288 Cr |
| Mar2022 | ₹122 Cr |
How is Deferred Tax Assets / Liabilities of AUROBINDO PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,178 Cr | Negative | |
| Mar2025 | ₹-990 Cr | Negative | |
| Mar2024 | ₹-856 Cr | Negative | |
| Mar2023 | ₹-288 Cr | Negative | |
| Mar2022 | ₹122 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹92,432.3 Cr | -3.1% | 4.8% | 50% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -3.1% |
4.8% |
50% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses